Free Trial
→ Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid (From Altimetry) (Ad)tc pixel Free HTGMQ Stock Alerts

HTG Molecular Diagnostics (HTGMQ) Competitors

Compare

HTGMQ vs. THMO, SXTPW, ACONW, DRTSW, and ALVOW

Should you buy HTG Molecular Diagnostics stock or one of its competitors? HTG Molecular Diagnostics's main competitors and comparable companies include ThermoGenesis (THMO), 60 Degrees Pharmaceuticals (SXTPW), Aclarion (ACONW), Alpha Tau Medical (DRTSW), and Alvotech (ALVOW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare" sector.

How does HTG Molecular Diagnostics compare to ThermoGenesis?

ThermoGenesis (NASDAQ:THMO) and HTG Molecular Diagnostics (NASDAQ:HTGMQ) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, media sentiment, valuation, analyst recommendations, risk, institutional ownership, profitability and earnings.

ThermoGenesis has a beta of 1.08, suggesting that its share price is 8% more volatile than the broader market. Comparatively, HTG Molecular Diagnostics has a beta of 3, suggesting that its share price is 200% more volatile than the broader market.

Company Net Margins Return on Equity Return on Assets
ThermoGenesisN/A N/A N/A
HTG Molecular Diagnostics N/A N/A N/A

ThermoGenesis has higher revenue and earnings than HTG Molecular Diagnostics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ThermoGenesis$9.61M0.00-$17.98M-$5.14N/A
HTG Molecular Diagnostics$6.37M0.00-$21.59MN/AN/A

5.8% of ThermoGenesis shares are owned by institutional investors. 78.0% of ThermoGenesis shares are owned by company insiders. Comparatively, 2.6% of HTG Molecular Diagnostics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

In the previous week, ThermoGenesis' average media sentiment score of 0.00 equaled HTG Molecular Diagnostics'average media sentiment score.

Company Overall Sentiment
ThermoGenesis Neutral
HTG Molecular Diagnostics Neutral

Summary

ThermoGenesis beats HTG Molecular Diagnostics on 5 of the 6 factors compared between the two stocks.

How does HTG Molecular Diagnostics compare to 60 Degrees Pharmaceuticals?

60 Degrees Pharmaceuticals (NASDAQ:SXTPW) and HTG Molecular Diagnostics (NASDAQ:HTGMQ) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, institutional ownership, profitability, media sentiment, dividends and earnings.

60 Degrees Pharmaceuticals has higher earnings, but lower revenue than HTG Molecular Diagnostics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
60 Degrees Pharmaceuticals$1.11MN/AN/AN/AN/A
HTG Molecular Diagnostics$6.37M0.00-$21.59MN/AN/A

In the previous week, 60 Degrees Pharmaceuticals' average media sentiment score of 0.00 equaled HTG Molecular Diagnostics'average media sentiment score.

Company Overall Sentiment
60 Degrees Pharmaceuticals Neutral
HTG Molecular Diagnostics Neutral

Company Net Margins Return on Equity Return on Assets
60 Degrees PharmaceuticalsN/A N/A N/A
HTG Molecular Diagnostics N/A N/A N/A

Summary

HTG Molecular Diagnostics beats 60 Degrees Pharmaceuticals on 1 of the 1 factors compared between the two stocks.

How does HTG Molecular Diagnostics compare to Aclarion?

Aclarion (NASDAQ:ACONW) and HTG Molecular Diagnostics (NASDAQ:HTGMQ) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, risk, institutional ownership, valuation, profitability, earnings, analyst recommendations and dividends.

In the previous week, Aclarion's average media sentiment score of 0.00 equaled HTG Molecular Diagnostics'average media sentiment score.

Company Overall Sentiment
Aclarion Neutral
HTG Molecular Diagnostics Neutral

Aclarion has higher earnings, but lower revenue than HTG Molecular Diagnostics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aclarion$83.77KN/AN/AN/AN/A
HTG Molecular Diagnostics$6.37M0.00-$21.59MN/AN/A

Company Net Margins Return on Equity Return on Assets
AclarionN/A N/A N/A
HTG Molecular Diagnostics N/A N/A N/A

Summary

HTG Molecular Diagnostics beats Aclarion on 1 of the 1 factors compared between the two stocks.

How does HTG Molecular Diagnostics compare to Alpha Tau Medical?

HTG Molecular Diagnostics (NASDAQ:HTGMQ) and Alpha Tau Medical (NASDAQ:DRTSW) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, analyst recommendations, media sentiment, earnings, risk, dividends, profitability and institutional ownership.

Alpha Tau Medical has lower revenue, but higher earnings than HTG Molecular Diagnostics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
HTG Molecular Diagnostics$6.37M0.00-$21.59MN/AN/A
Alpha Tau MedicalN/AN/AN/AN/AN/A

In the previous week, HTG Molecular Diagnostics' average media sentiment score of 0.00 equaled Alpha Tau Medical'saverage media sentiment score.

Company Overall Sentiment
HTG Molecular Diagnostics Neutral
Alpha Tau Medical Neutral

Company Net Margins Return on Equity Return on Assets
HTG Molecular DiagnosticsN/A N/A N/A
Alpha Tau Medical N/A N/A N/A

Summary

HTG Molecular Diagnostics beats Alpha Tau Medical on 1 of the 1 factors compared between the two stocks.

How does HTG Molecular Diagnostics compare to Alvotech?

Alvotech (NASDAQ:ALVOW) and HTG Molecular Diagnostics (NASDAQ:HTGMQ) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, media sentiment, profitability, analyst recommendations, valuation, risk, dividends and institutional ownership.

In the previous week, Alvotech had 3 more articles in the media than HTG Molecular Diagnostics. MarketBeat recorded 3 mentions for Alvotech and 0 mentions for HTG Molecular Diagnostics. Alvotech's average media sentiment score of 1.05 beat HTG Molecular Diagnostics' score of 0.00 indicating that Alvotech is being referred to more favorably in the media.

Company Overall Sentiment
Alvotech Positive
HTG Molecular Diagnostics Neutral

Alvotech has higher revenue and earnings than HTG Molecular Diagnostics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alvotech$491.95MN/AN/AN/AN/A
HTG Molecular Diagnostics$6.37M0.00-$21.59MN/AN/A

Company Net Margins Return on Equity Return on Assets
AlvotechN/A N/A N/A
HTG Molecular Diagnostics N/A N/A N/A

Summary

Alvotech beats HTG Molecular Diagnostics on 3 of the 3 factors compared between the two stocks.

Get HTG Molecular Diagnostics News Delivered to You Automatically

Sign up to receive the latest news and ratings for HTGMQ and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HTGMQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HTGMQ vs. The Competition

Export
MetricHTG Molecular DiagnosticsAnalytical instruments IndustryHealthcare SectorNASDAQ Exchange
Market CapN/AN/A$7.15B$13.26B
Dividend YieldN/AN/A2.53%17.36%
P/E Ratio0.00N/A274.3426.20
Price / SalesN/A0.00619.1192.00
Price / CashN/AN/A27.2234.70
Price / BookN/AN/A11.236.40
Net Income-$21.59M-$21.59M$3.49B$381.07M

HTG Molecular Diagnostics Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HTGMQ
HTG Molecular Diagnostics
N/AN/AN/AN/A$0.00$6.37MN/A53
THMO
ThermoGenesis
N/AN/AN/AN/A$1K$9.61MN/A25
SXTPW
60 Degrees Pharmaceuticals
N/A$0.03
+19.0%		N/A-30.1%$0.00$1.11MN/A3
ACONW
Aclarion
N/A$0.03
-6.0%		N/A-7.0%$0.00$83.77KN/A11
DRTSW
Alpha Tau Medical
N/A$4.12
+2.6%		N/A+1,030.0%$0.00N/AN/A121

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:HTGMQ) was last updated on 10/6/2026 by MarketBeat.com Staff.
From Our Partners
They're not telling you how bad this could get
Valuations have reached levels seen only a handful of times in the past century, while debt concerns and tarif...
Parkview Capital Group | Sponsoredtc pixel
This smart glasses tech is bringing the screen to your eyes
Global AI smart-glasses shipments surged 263% in the first half of 2026, and Citi projects the market could re...
The Tomorrow Investor | Sponsoredtc pixel
I've seen this movie before (last time: 17,556%)
My track record speaks for itself... KDA: 17,556%. PRE: 3,900%. OCEAN: 2,650%. Every single one was called ...
Crypto 101 Media | Sponsoredtc pixel
The AI Stock to Keep an Eye on Before Election Day (See Why)
In 2019, Charles Mizrahi named Marvell Technology his top AI pick. It's since climbed 1300 percent. Now he'...
Prosperity Research | Sponsoredtc pixel
A dividend every week of the year
Most dividend stocks pay quarterly, leaving long stretches of silence between paydays. For investors covering ...
Market Savvy | Sponsoredtc pixel
5 seconds
Bill Poulos put together a Top 10 Stocks to Buy This Quarter report, explaining each pick in plain English. ...
Profits Run | Sponsoredtc pixel